Stuart Orkin and Swee Lay Thein shared a Breakthrough Prize in Life Sciences for their research on genetic causes of sickle ...
A reduced-intensity bone marrow transplant regimen developed by Johns Hopkins physicians provides durable engraftment with ...
A $2.5 million gift by Ted W. Love and Joyce Y. Love to UCSF Benioff Children’s Hospitals will expand care for patients with ...
Two papers published in The New England Journal of Medicine highlight the potential of gene editing for treatment of sickle ...
Blood transfusion therapy remains an indispensable intervention in the management of sickle cell disease (SCD), mitigating life‐threatening complications such as vaso‐occlusive crises and stroke. The ...
As treatment and care continues to evolve, we must ensure that people living with this disease are able to advocate for access to care. It wasn’t so long ago that sickle cell disease (SCD) was ...
Stephanie Douglas joined the WJZ family in August 2025 as a morning reporter. Stephanie is no stranger to Baltimore. She is a Maryland native who's deeply passionate about journalism and knows how to ...
Sickle cell disease (SCD) is the most common inherited blood disorder in the United States. Approximately 10 percent of ...
About 10% of people hospitalized with sickle cell on Long Island between 2009 and 2022 faced a "major risk of mortality," ...
A reduced-intensity bone marrow transplant regimen developed by Johns Hopkins physicians provides durable engraftment with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results